Galactosemia
Test
-
Biochemical assay detecting galactose uridyl transferase and galactose-one-phosphate
(the Beutler test). Heat and humidity degrade the transferase,
yielding false positives.
-
Hill test: fluorometric assay for galactose, used with Beutler,
only positive after milk ingestion
-
Paigen E. coli phage test: more reliable, also identifies
other galactose disorders
-
Confirmatory test
-
Urine for non-reducing substances (+++ galatosemia, + galactokinase
or epimerase deficiency, ++ in Vit. C), if negative, likely problem with
fructose metabolism
-
serum galactose and gal-1-phosphate, erythrocyte gal-1-phosphate uridyltransferase
(by electrophoresis)
Genetics
-
Autosomal recessive
-
1:60,000 to 1:80,000
Pathology
-
A cellular deficiency in one of the enzymes needed to convert galactose
to glucose. Galactose-1-phosphate uridyl transferase (GALT) deficiency
is the defect in the severe form of the disease
Diagnosis
-
Symptoms occurs within the first two weeks of life: jaundice, vomiting,
lethargy, hepatosplenomegaly, cataracts, and failure to thrive may proceed
to severe morbidity from liver failure, sepsis, or bleeding. Death may
occur.
-
E. coli sepsis may be a presenting sign.
-
Physical findings include cerebral palsy, ataxia, seizures, mental retardation,
cataracts, and liver disease.
Treatment
-
A galactose-free diet for life. Normal IQs are possible if treatment
is started before 10 days of age, but learning and speech problems are
still common. Ovarian failure has occurred in the majority of treated
females.
Acknowledgment
This page is based on a 1998 presentation by Owen Rennert, Georgetown University
Medical Center, Department of Pediatrics, Division of Genetics.
Also see other Inborn Errors of Metabolism.
Please direct all comments to:
Last modification: January 10, 2000